Phibro Animal Health Corp SEC filings PAHC

Phibro Animal Health Corp has 774 filings in SEC EDGAR's recent list, going back to Sep 29, 1998. Its latest annual report, Form ARS, was filed on Sep 18, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, shareholder vote results). The company's fiscal year ends on June 30.

Phibro Animal Health Corp SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Sep 18, 2014 —
424B4 Prospectus Apr 14, 2014 —
S-1MEF Form s-1mef Apr 11, 2014 —
S-1/A Amended registration statement Apr 10, 2014 —
FWP Free writing prospectus Apr 10, 2014 —
S-1/A Amended registration statement Apr 8, 2014 —
S-1/A Amended registration statement Apr 4, 2014 —
S-1/A Amended registration statement Mar 31, 2014 —
S-1 Registration statement Mar 10, 2014 —
POS AM Post-effective amendment no. 1 to form s-4 Feb 24, 2005 —
S-4/A Amendment #1 to s-4: phibro animal health corp etal Feb 2, 2005 —
S-4 Registration for a merger or exchange Jan 14, 2005 —
S-4 Registration for a merger or exchange Feb 18, 2004 —
S-4/A Post-effective amendment no. 1 to s-4 Sep 22, 2000 —
S-4/A Amendment no. 3 Dec 17, 1998 —
S-4/A Amendment no. 2 Dec 14, 1998 —
S-4/A Amendment no. 1 Nov 23, 1998 —
S-4 Registration for a merger or exchange Sep 29, 1998 —

Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PAHC (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Teaneck, NJ
SEC filer status
Large accelerated filer
SEC CIK
1069899
Former names
PHILIPP BROTHERS CHEMICALS INC (until May 14, 2003)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.